daunorubicin has been researched along with Experimental Hepatoma in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (75.86) | 18.7374 |
| 1990's | 5 (17.24) | 18.2507 |
| 2000's | 2 (6.90) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dziegiel, P; Rabczyński, J; Surowiak, P; Zabel, M | 1 |
| Baggetto, LG; Barakat, S; Bernaud, J; Dayan, G; Devouassoux-Shisheboran, M; Gambrelle, J; Gayet, L; Grange, JD; Labialle, S; Rigal, D | 1 |
| Belles-Isles, M; Pagé, M | 1 |
| Bischof, WK; Hibi, N; Hirai, H; Hurwitz, E; Sela, M; Tsukada, Y | 1 |
| Hara, A; Hibi, N; Hirai, H; Hurwitz, E; Kashi, R; Sela, M; Tsukada, Y | 2 |
| Deutsch, HF; Hirai, H; Sasaki, T; Tsukada, Y | 2 |
| Hara, T; Hirai, H; Kato, Y; Takeda, Y; Tsukada, Y; Umemoto, N | 1 |
| Fukushima, H; Hara, T; Kato, Y; Kayama, Y; Takeda, Y; Tsukada, Y; Umemoto, N | 1 |
| Dehove, D; Laval, F | 1 |
| Arnon, R; Sela, M | 1 |
| Crooke, ST; DuVernay, VH; Pachter, JA | 1 |
| Banfi, P; Dragani, TA; Falvella, FS; Gambetta, RA; Gariboldi, M; Lanzi, C | 1 |
| Jelkmann, W; Wolff, M | 1 |
| Il'nitskaia, SI; Kaledin, VI | 1 |
| Pagé, M; Thibeault, D | 1 |
| Satoh, H; Taguchi, H; Yahagi, S | 1 |
| Hibi, N; Ohkawa, K; Tsukada, Y | 2 |
| Aldrich, MB; Chan, PK; Yung, BY | 1 |
| Abe, T; Hibi, N; Ohkawa, K; Takada, K; Tsukada, Y | 1 |
| Tsukada, Y | 1 |
| Ellis, AL; Gewirtz, DA; Randolph, JK; Woods, KE | 1 |
| Chan, PK; Slater, LM; Sweet, P | 1 |
| Kobayashi, T | 1 |
| Ellis, A; Gewirtz, D; Munger, C; Randolph, J; Woods, K; Yanovich, S | 1 |
| Koopman, G; Lankelma, J; Pinedo, HM; van Grondelle, R | 1 |
| Gupta, S; Meador, J; Murray, S; Slater, L; Stupecky, M; Sweet, P; Wetzel, M | 1 |
1 review(s) available for daunorubicin and Experimental Hepatoma
| Article | Year |
|---|---|
In vitro and in vivo efficacy of conjugates of daunomycin with anti-tumor antibodies.
Topics: Animals; Antibodies, Neoplasm; Antibody Specificity; Daunorubicin; Doxorubicin; Drug Combinations; Drug Evaluation, Preclinical; Immunoglobulin Fab Fragments; Liver Neoplasms; Liver Neoplasms, Experimental; Lymphoma; Macromolecular Substances; Mice; Neoplasms; Neoplasms, Experimental; Rats | 1982 |
28 other study(ies) available for daunorubicin and Experimental Hepatoma
| Article | Year |
|---|---|
Effect of melatonin on cytotoxic effects of daunorubicin on myocardium and on transplantable Morris hepatoma in rats.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Daunorubicin; Heart; In Situ Nick-End Labeling; Liver Neoplasms, Experimental; Melatonin; Myocardium; Necrosis; Rats; Tumor Cells, Cultured | 2002 |
Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Liver Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred C57BL; Mice, Nude; Multidrug Resistance-Associated Proteins; Neoplasm Metastasis; Neoplasm Proteins; Skin Neoplasms; Uveal Neoplasms; Vault Ribonucleoprotein Particles | 2005 |
In vitro activity of daunomycin-anti-alphafoetoprotein conjugate on mouse hepatoma cells.
Topics: alpha-Fetoproteins; Animals; Carrier Proteins; Cell Survival; Cells, Cultured; Daunorubicin; Dose-Response Relationship, Drug; Immunoglobulins; Liver Neoplasms, Experimental; Mice; Mitosis | 1980 |
Effect of a conjugate of daunomycin and antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
Topics: alpha-Fetoproteins; Animals; Antibodies; Antigen-Antibody Complex; Cell Line; Cell Survival; Daunorubicin; Liver Neoplasms, Experimental; Rats | 1982 |
Chemotherapy by intravenous administration of conjugates of daunomycin with monoclonal and conventional anti-rat alpha-fetoprotein antibodies.
Topics: alpha-Fetoproteins; Animals; Daunorubicin; Liver Neoplasms, Experimental; Rats | 1982 |
Effect of a conjugate of daunomycin and purified polyclonal or monoclonal antibodies to rat alpha-fetoprotein on the growth of alpha-fetoprotein-producing tumor cells.
Topics: alpha-Fetoproteins; Animals; Antibodies, Monoclonal; Cell Line; Cell Survival; Daunorubicin; Dosage Forms; Horses; Hybridomas; Immunoglobulins; Liver Neoplasms, Experimental; Mice; Rats | 1983 |
Daunomycin-arachidonic acid complex as a potential new antitumor agent.
Topics: alpha-Fetoproteins; Animals; Arachidonic Acids; Daunorubicin; Liver Neoplasms, Experimental; Rats | 1984 |
An anti-alpha-fetoprotein antibody-daunorubicin conjugate with a novel poly-L-glutamic acid derivative as intermediate drug carrier.
Topics: alpha-Fetoproteins; Animals; Cell Line; Daunorubicin; Drug Evaluation, Preclinical; Immunodiffusion; Indicators and Reagents; Liver Neoplasms, Experimental; Male; Peptides; Polyglutamic Acid; Pyridines; Rats; Rats, Inbred Strains | 1984 |
A novel method of conjugation of daunomycin with antibody with a poly-L-glutamic acid derivative as intermediate drug carrier. An anti-alpha-fetoprotein antibody-daunomycin conjugate.
Topics: alpha-Fetoproteins; Animals; Antibodies; Cell Line; Cell Survival; Daunorubicin; Drug Evaluation, Preclinical; Immune Sera; Indicators and Reagents; Liver Neoplasms, Experimental; Rats; Spectrophotometry, Ultraviolet | 1984 |
Cytotoxic effects of daunomycin-fatty acid complexes on rat hepatoma cells.
Topics: Animals; Cell Line; Cell Survival; Chromatography, Thin Layer; Daunorubicin; Fatty Acids; Liver Neoplasms, Experimental; Rats; Spectrophotometry, Ultraviolet | 1983 |
Influence of daunorubicin on the survival of X-irradiated mammalian cells.
Topics: Animals; Cell Survival; Daunorubicin; DNA Repair; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Gamma Rays; Liver Neoplasms, Experimental; Radiation-Sensitizing Agents; Radiation, Ionizing; Radiotherapy; Rats; Time Factors; X-Rays | 1980 |
Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.
Topics: Animals; Carubicin; Cells, Cultured; Daunorubicin; DNA; DNA, Neoplasm; DNA, Superhelical; Doxorubicin; Leukemia L1210; Liver Neoplasms, Experimental; Mice; Rats; RNA, Neoplasm; Structure-Activity Relationship | 1980 |
The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines.
Topics: Aldehyde Dehydrogenase; Animals; Blotting, Northern; Blotting, Western; Carrier Proteins; Daunorubicin; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred A; Mice, Inbred C3H; Rats; Tumor Cells, Cultured | 1994 |
Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures.
Topics: Animals; Antineoplastic Agents; Azathioprine; Colchicine; Cyclophosphamide; Cyclosporine; Cytarabine; Daunorubicin; Erythropoietin; Humans; Ifosfamide; Immunosuppressive Agents; L-Lactate Dehydrogenase; Liver Neoplasms, Experimental; Methotrexate; Organoplatinum Compounds; Tetrazolium Salts; Tumor Cells, Cultured; Vincristine | 1993 |
[Effectiveness of free and liposomal forms of platinum and anthracycline antibiotics for hepatic metastasis of GA-1 and P-388 tumors in mice].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Daunorubicin; Disease Models, Animal; Doxorubicin; Drug Carriers; Leukemia P388; Liposomes; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred A; Mice, Inbred DBA; Platinum Compounds | 1996 |
Coupling daunorubicin to monoclonal antialphafoetoprotein with a new activated derivative.
Topics: alpha-Fetoproteins; Animals; Antibodies, Monoclonal; Cell Survival; Daunorubicin; Drug Interactions; Glutaral; Humans; Immunotoxins; Liver Neoplasms, Experimental; Mice; Tumor Cells, Cultured | 1990 |
[Antitumor spectrum of TUT-7 on rat ascitic hepatoma].
Topics: Animals; Antineoplastic Agents; Daunorubicin; Drug Evaluation, Preclinical; Female; Liver Neoplasms, Experimental; Menogaril; Nogalamycin; Rats; Rats, Inbred Strains | 1990 |
Suppression of human alpha-foetoprotein-producing hepatocellular carcinoma growth in nude mice by an anti alpha-foetoprotein antibody-daunorubicin conjugate with a poly-L-glutamic acid derivative as intermediate drug carrier.
Topics: alpha-Fetoproteins; Animals; Antibodies; Antibodies, Neoplasm; Body Weight; Cytotoxicity, Immunologic; Daunorubicin; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Mitosis; Pharmaceutical Vehicles; Polyglutamic Acid | 1985 |
Nucleolar protein B23 translocation after doxorubicin treatment in murine tumor cells.
Topics: Animals; Dactinomycin; Daunorubicin; Doxorubicin; Fluorescent Antibody Technique; HeLa Cells; Humans; Leukemia P388; Leukemia, Experimental; Liver Neoplasms, Experimental; Mice; Microscopy, Phase-Contrast; Nuclear Proteins; Nucleophosmin; Ribonucleoproteins; RNA | 1987 |
Therapeutic effect of treatment with polyclonal or monoclonal antibodies to alpha-fetoprotein that have been conjugated to daunomycin via a dextran bridge: studies with an alpha-fetoprotein-producing rat hepatoma tumor model.
Topics: alpha-Fetoproteins; Animals; Antibodies; Antibodies, Monoclonal; Daunorubicin; Dextrans; Liver Neoplasms, Experimental; Neoplasm Metastasis; Rats | 1987 |
Overcoming effect of antibody against rat alpha-fetoprotein (AFP) on the growth of daunorubicin-resistant mutant rat ascites hepatoma cell line AH66.
Topics: alpha-Fetoproteins; Animals; Cell Division; Daunorubicin; Deoxyglucose; Drug Resistance; Immune Sera; Liver Neoplasms, Experimental; Phosphorylation; Rats; Tumor Cells, Cultured | 1989 |
[Chemical modification of anti-cancer drugs to increase their affinity to tumor antigens].
Topics: alpha-Fetoproteins; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antineoplastic Agents; Daunorubicin; Doxorubicin; Humans; Liver Neoplasms, Experimental; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Rats | 1985 |
Enhanced sensitivity of the rat hepatoma cell to the daunorubicin analogue 4-demethoxydaunorubicin associated with induction of DNA damage.
Topics: Animals; Cell Division; Cell Membrane; Daunorubicin; Deferoxamine; DNA Damage; DNA, Neoplasm; Doxorubicin; Drug Screening Assays, Antitumor; Free Radicals; Idarubicin; Liver Neoplasms, Experimental; Rats; Tumor Cells, Cultured | 1989 |
Cyclosporin A and verapamil enhancement of daunorubicin-produced nucleolar protein B23 translocation in daunorubicin-resistant and -sensitive human and murine tumor cells.
Topics: Animals; Cell Line; Cyclosporins; Daunorubicin; Drug Resistance; Humans; Liver Neoplasms, Experimental; Mice; Nuclear Proteins; Nucleophosmin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Verapamil | 1989 |
[New developments in chemotherapy for experimental brain metastasis].
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Daunorubicin; Doxorubicin; Floxuridine; Hydantoins; Leukemia, Myeloid; Liver Neoplasms, Experimental; Lomustine; Meningeal Neoplasms; Methotrexate; Neoplasm Transplantation; Nimustine; Nitrogen Mustard Compounds; Nitrosourea Compounds; Procarbazine; Rats | 1985 |
Evidence for inhibition of growth related to compromised DNA synthesis in the interaction of daunorubicin with H-35 rat hepatoma.
Topics: Animals; Cell Division; Cell Membrane; Cytoplasm; Daunorubicin; DNA; DNA Damage; Free Radicals; Liver Neoplasms, Experimental; Mitochondria; Rats; Tumor Cells, Cultured | 1988 |
In-beam light absorption measurement of anthracyclines in cells with a flow-through system.
Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Daunorubicin; Liver Neoplasms, Experimental; Naphthacenes; Rats; Spectrophotometry | 1988 |
Enhancement by cyclosporin A of daunorubicin efficacy in Ehrlich ascites carcinoma and murine hepatoma 129.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Cyclosporins; Daunorubicin; DNA Replication; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C | 1987 |